Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filoche

Showing results (201-210 of 217) with videos related to

Pageof 22
Sort By:
Nature Chemical Biology|October 20, 2014
A highly potent and selective Vps34 inhibitor alters vesicle trafficking and autophagyBaptiste Ronan, Odile Flamand, Lionel Vescovi, et al.
Gastroenterologie Clinique Et Biologique|June 2, 2007
Routine practice HCV infection screening with saliva samples: multicentric study in an intravenous drug user populationDamien Lucidarme, Anne Decoster, Didier Fremaux, et al.
Gastroenterologie Clinique Et Biologique|April 25, 2001
[Patients with alcoholic liver disease hospitalized in gastroenterology. A national multicenter study]S Naveau, V Giraud, N Ganne, et al.
Bioorganic & Medicinal Chemistry Letters|February 25, 2014
Preparation and optimization of new 4-(2-(indolin-1-yl)-2-oxoethyl)-2-morpholinothiazole-5-carboxylic acid and amide derivatives as potent and selective PI3Kβ inhibitorsVictor Certal, Frank Halley, Angela Virone-Oddos, et al.
Endoscopy|August 16, 2012
Prospective multicenter evaluation of colon capsule examination indicated by colonoscopy failure or anesthesia contraindicationM Pioche, A de Leusse, B Filoche, et al.
Bioorganic & Medicinal Chemistry Letters|September 18, 2012
Preparation and optimization of new 4-(morpholin-4-yl)-(6-oxo-1,6-dihydropyrimidin-2-yl)amide derivatives as PI3Kβ inhibitorsVictor Certal, Frank Halley, Angela Virone-Oddos, et al.
Placenta|December 24, 2017
IFPA meeting 2017 workshop report: Clinical placentology, 3D structure-based modeling of placental function, placental bed, and treating placental dysfunctionGanesh Acharya, John Aplin, Paul Brownbill, et al.
Journal of Medicinal Chemistry|April 25, 2012
Discovery and optimization of new benzimidazole- and benzoxazole-pyrimidone selective PI3Kβ inhibitors for the treatment of phosphatase and TENsin homologue (PTEN)-deficient cancersVictor Certal, Frank Halley, Angela Virone-Oddos, et al.
Journal of Critical Care|May 28, 2011
Proceedings from the Montebello Round Table Discussion. Second annual conference on Complexity and Variability discusses research that brings innovation to the bedsideAndrew J E Seely, Stuart A Kauffman, Jason H T Bates, et al.
Molecular Cancer Therapeutics|December 14, 2020
SAR439859, a Novel Selective Estrogen Receptor Degrader (SERD), Demonstrates Effective and Broad Antitumor Activity in Wild-Type and Mutant ER-Positive Breast Cancer ModelsMaysoun Shomali, Jane Cheng, Fangxian Sun, et al.
Pageof 22

Showing results (201-210 of 217) with videos related to

Sort By:
Pageof 22
Nature Chemical Biology|October 20, 2014
A highly potent and selective Vps34 inhibitor alters vesicle trafficking and autophagyBaptiste Ronan, Odile Flamand, Lionel Vescovi, et al.
Gastroenterologie Clinique Et Biologique|June 2, 2007
Routine practice HCV infection screening with saliva samples: multicentric study in an intravenous drug user populationDamien Lucidarme, Anne Decoster, Didier Fremaux, et al.
Gastroenterologie Clinique Et Biologique|April 25, 2001
[Patients with alcoholic liver disease hospitalized in gastroenterology. A national multicenter study]S Naveau, V Giraud, N Ganne, et al.
Bioorganic & Medicinal Chemistry Letters|February 25, 2014
Preparation and optimization of new 4-(2-(indolin-1-yl)-2-oxoethyl)-2-morpholinothiazole-5-carboxylic acid and amide derivatives as potent and selective PI3Kβ inhibitorsVictor Certal, Frank Halley, Angela Virone-Oddos, et al.
Endoscopy|August 16, 2012
Prospective multicenter evaluation of colon capsule examination indicated by colonoscopy failure or anesthesia contraindicationM Pioche, A de Leusse, B Filoche, et al.
Bioorganic & Medicinal Chemistry Letters|September 18, 2012
Preparation and optimization of new 4-(morpholin-4-yl)-(6-oxo-1,6-dihydropyrimidin-2-yl)amide derivatives as PI3Kβ inhibitorsVictor Certal, Frank Halley, Angela Virone-Oddos, et al.
Placenta|December 24, 2017
IFPA meeting 2017 workshop report: Clinical placentology, 3D structure-based modeling of placental function, placental bed, and treating placental dysfunctionGanesh Acharya, John Aplin, Paul Brownbill, et al.
Journal of Medicinal Chemistry|April 25, 2012
Discovery and optimization of new benzimidazole- and benzoxazole-pyrimidone selective PI3Kβ inhibitors for the treatment of phosphatase and TENsin homologue (PTEN)-deficient cancersVictor Certal, Frank Halley, Angela Virone-Oddos, et al.
Journal of Critical Care|May 28, 2011
Proceedings from the Montebello Round Table Discussion. Second annual conference on Complexity and Variability discusses research that brings innovation to the bedsideAndrew J E Seely, Stuart A Kauffman, Jason H T Bates, et al.
Molecular Cancer Therapeutics|December 14, 2020
SAR439859, a Novel Selective Estrogen Receptor Degrader (SERD), Demonstrates Effective and Broad Antitumor Activity in Wild-Type and Mutant ER-Positive Breast Cancer ModelsMaysoun Shomali, Jane Cheng, Fangxian Sun, et al.
Pageof 22